CRISPR Products for Genome Editing
- CRISPR KO Vectors & Virus
- CRISPR Activation/Repression
- Cas9 Vectors & Virus
- Cas Proteins & CRISPR Screening
abm, a leader in genetic engineering tool development for the last 15 years, holds a CRISPR license with ERS, co-founded by 2020 Nobel Prize winner Dr. Emmanuelle Charpentier, granting access to the ERS CRISPR/Cas9 patent portfolio, enabling us to offer a full line of CRISPR Products for research.
This portfolio has more than 55 patents in the US covering the use of CRISPR/Cas9 gene editing in all cells, including eukaryotic. Companies based in the US, using CRISPR/Cas9 will require a CVC license.
This portfolio has more than 55 patents in the US covering the use of CRISPR/Cas9 gene editing in all cells, including eukaryotic. Companies based in the US, using CRISPR/Cas9 will require a CVC license.
Search CRISPR sgRNA Library
Search our extensive collection of CRISPR products using gene name or accession number:
Search results will be displayed here
Highlighted Products and Services
Products
Resources
-
Introduction to CRISPR
CRISPR Knowledge Base -
CRISPR-Methods and Tools
CRISPR Knowledge Base -
CRISPR-gRNA Design
CRISPR Knowledge Base -
CRISPR for Gene Activation and Repression
CRISPR Knowledge Base
-
CRISPR, TALEN & RNAi
CRISPR Knowledge Base -
CRISPR Knockout Manual
CRISPR Guides/Manuals -
CRISPR Case Studies
CRISPR Guides/Manuals -
CRISPR KO Results
Our data speaks for itself
Top Publications
Inferring and pertubing cell fate regulomes in human brain organoids.
Fleck, JS et al.
Nature. (2022)
doi: 10.1038/s41586-022-05279-8.
Gangliosides are essential endosomal receptors for quasi-enveloped and naked hepatitis A virus.
Das, A. et al.
Nature Microbiology (2020)
doi: 10.1038/s41564-020-0727-8
Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses.
Yamane, D. et al.
Nature Microbiology. (2019)
doi: 10.1038/s41564-019-0425-6